Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2004 drug approval highlights: FDA update.

× No keyword cloud information.

5 in total

1. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.

Authors: Jie Cheng; Yatrik M Shah; Xiaochao Ma; Xiaoyan Pang; Toshiya Tanaka; Tatsuhiko Kodama; Kristopher W Krausz; Frank J Gonzalez
Journal: J Pharmacol Exp Ther Date: 2010-07-13 Impact factor: 4.030

2. Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.

Authors: Hugo Geerts; Athan Spiros; Patrick Roberts; Robert Carr
Journal: J Pharmacokinet Pharmacodyn Date: 2013-01-22 Impact factor: 2.745

3. Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer.

Authors: Swetlana Gautam; Priyanka Singh; Manjari Singh; Subhadeep Roy; Jitendra K Rawat; Rajnish K Yadav; Uma Devi; Pushpraj S Gupta; Shubhini A Saraf; Gaurav Kaithwas
Journal: RSC Adv Date: 2018-01-17 Impact factor: 4.036

Review 4. The pregnane X receptor: from bench to bedside.

Authors: Xiaochao Ma; Jeffrey R Idle; Frank J Gonzalez
Journal: Expert Opin Drug Metab Toxicol Date: 2008-07 Impact factor: 4.481

Review 5. Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD.

Authors: Victoria Klepsch; Alexander R Moschen; Herbert Tilg; Gottfried Baier; Natascha Hermann-Kleiter
Journal: Front Immunol Date: 2019-05-14 Impact factor: 7.561

5 in total